Donor CD8+ T cells prevent toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3414-3425

  Bhadra, Rajarshi ^a   Cobb, Dustin A ^a   Khan, Imtiaz A ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; INNATE IMMUNITY; INTERMEDIATE HOST; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 84884235549     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00784-12     Document Type: Article

References (51)

1. Kur J, Holec-Gasior L, Hiszczynska-Sawicka E. 2009. Current status of toxoplasmosis vaccine development. Expert Rev. Vaccines 8:791-808.
2. Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, MinkoffH, Piessens E, Kovacs A, Anastos K, Cohen MH. 2002. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin. Infect. Dis. 35:1414-1417.
3. Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. 1990. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 4:519-521.
4. Bhadra R, Gigley JP, Khan IA. 2011. The CD8 T-cell road to immunotherapy of toxoplasmosis. Immunotherapy 3:789-801.
5. Gigley JP, Bhadra R, Khan IA. 2011. CD8 T cells and Toxoplasma gondii: a new paradigm. J. Parasitol. Res. 2011:243796. doi:10.1155/2011/243796.
6. Mui EJ, Schiehser GA, Milhous WK, Hsu H, Roberts CW, Kirisits M, Muench S, Rice D, Dubey JP, Fowble JW, Rathod PK, Queener SF, Liu SR, Jacobus DP, McLeod R. 2008. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl. Trop. Dis. 2:e190. doi:10.1371/journal.pntd.0000190.
7. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J. 1999. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill. Summ. 48:1-22.
8. Vidal JE, Hernandez AV, de Oliveira AC, Dauar RF, Barbosa SP, Jr, Focaccia R. 2005. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS 19:626-634.
9. Lindström I, Kaddu-Mulindwa DH, Kironde F, Lindh J. 2006. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIVpatients from Uganda. Acta Trop. 100:218-222.
10. Pradhan S, Yadav R, Mishra VN. 2007. Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome. Trans. R. Soc. Trop. Med. Hyg. 101:25-33.
11. Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP. 2006. Globalization and the population structure of Toxoplasma gondii. Proc. Natl. Acad. Sci. U. S. A. 103:11423-11428.
12. Carme B, Demar M, Ajzenberg D, Darde ML. 2009. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg. Infect. Dis. 15:656-658.
13. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R, Jr, Vitor RW, Silveira C, Sibley LD. 2006. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 12:942-949.
14. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. 1992. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175-180.
15. Suzuki Y, Conley FK, Remington JS. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050.
16. Bhadra R, Gigley JP, Weiss LM, Khan IA. 2011. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. U. S. A. 108:9196-9201.
17. Bhadra R, Gigley JP, Khan IA. 2011. Cutting edge: CD40-CD40 ligand pathway plays a critical CD8-intrinsic and -extrinsic role during rescue of exhausted CD8 T cells. J. Immunol. 187:4421-4425.
18. Bhadra R, Gigley JP, Khan IA. 2012. PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection. J. Infect. Dis. 206:125-134.
19. Bhadra R, Khan IA. 2012. Redefining chronic toxoplasmosis-a T cell exhaustion perspective. PLoS Pathog. 8:e1002903. doi:10.1371/journal.ppat.1002903.
20. Bhadra R, Cobb DA, Weiss LM, Khan IA. 2013. Psychiatric disorders in toxoplasma seropositive patients-the CD8 connection. Schizophr. Bull. 39:485-489.
21. Khan IA, Kasper LH. 1996. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:2103-2108.
22. Wetzel DM, Hakansson S, Hu K, Roos D, Sibley LD. 2003. Actin filament polymerization regulates gliding motility by apicomplexan parasites. Mol. Biol. Cell 14:396-406.
23. PfafflMW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
24. Bhadra R, Khan IA. 2012. IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite. Microbes Infect. 14:1160-1168.
25. Lyons RE, McLeod R, Roberts CW. 2002. Toxoplasma gondii tachyzoitebradyzoite interconversion. Trends Parasitol. 18:198-201.
26. Ferguson DJ, Hutchison WM. 1987. The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch. A Pathol. Anat. Histopathol. 411:39-43.
27. Dubey JP, Lindsay DS, Speer CA. 1998. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11:267-299.
28. Dzierszinski F, Mortuaire M, Dendouga N, Popescu O, Tomavo S. 2001. Differential expression of two plant-like enolases with distinct enzymatic and antigenic properties during stage conversion of the protozoan parasite Toxoplasma gondii. J. Mol. Biol. 309:1017-1027.
29. Fux B, Nawas J, Khan A, Gill DB, Su C, Sibley LD. 2007. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect. Immun. 75:2580-2590.
30. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. 2006. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107:309-316.
31. Wang X, Claflin J, Kang H, Suzuki Y. 2005. Importance of CD8(+)Vbeta8(+) T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. J. Interferon Cytokine Res. 25:338-344.
32. Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsacker F, Blum HE, Pircher H, Thimme R. 2007. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81:945-953.
33. Voehringer D, Koschella M, Pircher H. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100:3698-3702.
34. Bustamante JM, Bixby LM, Tarleton RL. 2008. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 14:542-550.
35. Galea I, Bernardes-Silva M, Forse PA, van Rooijen N, Liblau RS, Perry VH. 2007. An antigen-specific pathway for CD8 T cells across the bloodbrain barrier. J. Exp. Med. 204:2023-2030.
36. Sobbe M, Bilzer T, Gommel S, Noske K, Planz O, Stitz L. 1997. Induction of degenerative brain lesions after adoptive transfer of brain lymphocytes from Borna disease virus-infected rats: presence of CD8+ T cells and perforin mRNA. J. Virol. 71:2400-2407.
37. Suzuki Y, Remington JS. 1988. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J. Immunol. 140:3943-3946.
38. Bhadra R, Guan H, Khan IA. 2010. Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii. PLoS One 5:e10842. doi:10.1371/journal.pone.0010842.
39. Wherry EJ. 2011. T cell exhaustion. Nat. Immunol. 12:492-499.
40. Yap G, Pesin M, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:628-631.
41. Fox BA, Falla A, Rommereim LM, Tomita T, Gigley JP, Mercier C, Cesbron-Delauw MF, Weiss LM, Bzik DJ. 2011. Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot. Cell 10:1193-1206.
42. Djurković-Djaković O, Milenkovic V, Nikolic A, Bobic B, Grujic J. 2002. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. J. Antimicrob. Chemother. 50:981-987.
43. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM, Banerjee A, Longworth SA, Vinup KE, Mrass P, Oliaro J, Killeen N, Orange JS, Russell SM, Weninger W, Reiner SL. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315:1687-1691.
44. Suzuki Y, Wang X, Jortner BS, Payne L, Ni Y, Michie SA, Xu B, Kudo T, Perkins S. 2010. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am. J. Pathol. 176:1607-1613.
45. Schlüter D, Deckert-Schluter M, Lorenz E, Meyer T, RollinghoffM, Bogdan C. 1999. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondiiresistant BALB/c mice. J. Immunol. 162:3512-3518.
46. Dulgerian LR, Garrido VV, Stempin CC, Cerban FM. 2011. Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection. Immunology 133:29-40.
47. Mueller SN, Ahmed R. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 106:8623-8628.
48. Wirth TC, Xue HH, Rai D, Sabel JT, Bair T, Harty JT, Badovinac VP. 2010. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33:128-140.
49. Kasagi S, Kawano S, Kumagai S. 2011. PD-1 and autoimmunity. Crit. Rev. Immunol. 31:265-295.
50. Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. 2010. Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 185:4988-4992.
51. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, Kaech SM. 2009. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31:296-308.